Background illustration for clinical trials search

Paid Clinical Trials New Jersey

Discover 1,676 paid clinical trials in New Jersey. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Exercise and Intranasal Insulin in Type 2 Diabetes

for
Type 2 Diabetes, Insulin Sensitivity/Resistance, Cognition,
Location: New Brunswick NJ, Piscataway NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 55 - 70+

Code: NCT07675499

Phase 2, Phase 3, Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: Boston MA, New York NY, East Brunswick NJ, Baltimore MD,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase 2, Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-related Macular Degeneration, nAMD
Location: Boston MA, Waterford CT, Oceanside NY, Scarsdale NY,
Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase 3, Recruiting

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

for
Solid Tumor, Solid Carcinoma, Advanced Solid Tumor,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07638371

Phase 1, Recruiting

A Study of Lower Dose Radiation Therapy for People With Prostate Cancer

for
Prostate Cancer, Prostate Adenocarcinoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male

Age: 18+

Code: NCT07635238

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

for
Non-small Cell Lung Cancer (NSCLC)
Location: Edison NJ, New Brunswick NJ, Arlington VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566052

Phase 3, Recruiting

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

for
Advanced Malignant Tumors
Location: Quebec, Hackensack NJ, Germantown TN, Vancouver
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06764771

Phase 1, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Shirley NY, Stony Brook NY, Danbury CT, Mineola NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase 3, Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

for
Ovarian Cancer
Location: Scarborough ME, Worcester MA, New York NY, Camden NJ,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07059845

Phase 2, Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for
Astrocytoma, IDH-Mutant, Grade 3
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 12+

Code: NCT07215910

Phase 3, Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

for
Metastatic Castration-Resistant Prostate Carcinoma,
Location: Commack NY, Uniondale NY, Harrison NY, The Bronx NY,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT07200830

Phase 3, Recruiting

Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

for
Multiple Sclerosis, Lower Urinary Track Symptoms
Location: Morristown NJ
Sponsor: Atlantic Health System

Sex: Female

Age: 18+

Code: NCT07614321

Recruiting

Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

for
Coronary Artery Disease,
Location: The Bronx NY, New York NY, Paramus NJ, Camden NJ,
Sponsor: Supira Medical

Sex: All

Age: 18 - 70+

Code: NCT07296744

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-related Epilepsy

for
KCNT1-Related Epilepsy
Location: Hackensack NJ
Sponsor: Actio Biosciences, Inc.

Sex: All

Age: 0 - 21

Code: NCT07600736

Phase 2, Recruiting

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

for
Gout
Location: Hartsdale NY, Brooklyn NY, Sparta NJ, Oxon Hill MD,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07535034

Phase 2, Recruiting

Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving Psychological Health in People With Brain Injury

for
Mild Traumatic Brain Injury, Alexithymia
Location: Edison NJ, Indianapolis IN
Sponsor: Hackensack Meridian Health

Sex: All

Age: 18+

Code: NCT07436754

Recruiting

The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes

for
Microdeletion 3q29 Syndrome, Microduplication 3q29 Syndrome
Location: Piscataway NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 0+

Code: NCT02447861

Recruiting

A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

for
Gastric Cancer, Gastroesophageal-junction Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07631000

Phase 2, Recruiting

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Boston MA, East Brunswick NJ, Fairfax VA, Tampa FL,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07383506

Phase 1, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, Shirley NY, Farmington CT, Mineola NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

Popular cities in New Jersey

New Jersey is a vital center for a diverse array of clinical trials, largely in part due to its robust healthcare network and prominent medical research institutions. Key organizations such as Rutgers Cancer Institute, Hackensack Meridian Health, and Cooper University Health Care are leading the way in groundbreaking studies in the state. These institutions are recognized for their innovative research in areas like cancer, cardiovascular health, and neurology, making New Jersey a critical player in advancing medical science and patient care.

Why choose New Jersey for clinical trials?

New Jersey offers a vast array of advantages for individuals considering participation in clinical trials. The state has a diverse population, which enriches the participant pool and improves the reliability and applicability of research findings. Additionally, New Jersey is home to some of the nation’s leading medical research institutions, known for their innovative approaches and focus on advancing healthcare.

By choosing to participate in a clinical trial in New Jersey, participants not only gain access to cutting-edge treatments but also play a vital role in advancing important medical research. The state’s well-established clinical research infrastructure ensures participants receive exceptional care and support throughout their journey, contributing to meaningful advancements in healthcare.

Common conditions studied in New Jersey

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New Jersey